James S Butler - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

James S Butler

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2012

Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particlesTomoko Nakayama, James S Butler, Alfica Sehgal, et al.

The New England Journal of Medicine|August 30, 2013

Safety and efficacy of RNAi therapy for transthyretin amyloidosisTeresa Coelho, David Adams, Ana Silva, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2012

Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particlesTomoko Nakayama, James S Butler, Alfica Sehgal, et al.

The New England Journal of Medicine|August 30, 2013

Safety and efficacy of RNAi therapy for transthyretin amyloidosisTeresa Coelho, David Adams, Ana Silva, et al.

Pageof 3